Volume 55, Issue 3 pp. 660-665
ORIGINAL ARTICLE

Pharmacokinetics of isoniazid in children with tuberculosis—A comparative study at two doses

Ira Shah MD

Corresponding Author

Ira Shah MD

Pediatric TB Clinic, Department of Pediatric Infectious Diseases, B J Wadia Hospital for Children, Mumbai, India

Correspondence Ira Shah, Pediatric TB Clinic, Department of Pediatric Infectious Diseases, B J Wadia Hospital for Children, Mumbai 400012, India.

Email: [email protected]

Search for more papers by this author
Sajal Kumar Das MD

Sajal Kumar Das MD

Pediatric TB Clinic, Department of Pediatric Infectious Diseases, B J Wadia Hospital for Children, Mumbai, India

Search for more papers by this author
Naman S. Shetty MBBS

Naman S. Shetty MBBS

Pediatric TB Clinic, Department of Pediatric Infectious Diseases, B J Wadia Hospital for Children, Mumbai, India

Search for more papers by this author
T. Kannan MSc

T. Kannan MSc

Department of Clinical Pharmacology, National Institute for Research in Tuberculosis, Chennai, India

Search for more papers by this author
Geetha Ramachandran PhD

Geetha Ramachandran PhD

Department of Clinical Pharmacology, National Institute for Research in Tuberculosis, Chennai, India

Search for more papers by this author
AK Hemanth Kumar PhD

AK Hemanth Kumar PhD

Department of Clinical Pharmacology, National Institute for Research in Tuberculosis, Chennai, India

Search for more papers by this author
First published: 07 January 2020
Citations: 4

Abstract

Aim

To compare the pharmacokinetics of isoniazid (INH) at doses 5 and 10 mg/kg/day.

Methods

INH concentrations were estimated by high-performance liquid chromatography in 24 Indian children aged 1 to 15 years on antituberculosis therapy. Blood samples were collected at 0, 2, 4, 6, 8 hours after administration of INH. Patients were randomly given INH at 5 or 10 mg/kg/day and maximum concentrations (Cmax) and area under the curve (AUC(0-8)) were determined in each group. The 2-hour concentration of INH was used as Cmax for this study.

Results

Mean (standard deviation) Cmax was reached in 2 hours and was 2.68 ± 1.19 µg/mL in 5 mg/kg/day group and 8.86 ± 3.94 µg/mL in 10 mg/kg/day group (P < .05). The normal therapeutic range at 2-hour concentrations for INH in adults achieving good clinical response is between 3 and 5 µg/mL. Among 5 mg/kg/day, only 4 (33%) patients had INH concentrations within the 2-hour concentrations therapeutic range whereas in 10 mg/kg/day group, 11 (91%) patients achieved Cmax higher than the 2-hour concentrations therapeutic range and 1 (9%) patient had Cmax within the 2-hour concentrations therapeutic range. The mean AUC(0-8) in 5 mg/kg/day group was 10.04 ± 6.12 and 35.93 ± 25.37 µg·h/mL in 10 mg/kg/day group (P = .0001).

Conclusion

Children on daily INH 10 mg/kg/day have higher AUC and Cmax than the required therapeutic range whereas over 65% of children with daily 5 mg/kg/day INH therapy failed to achieve the optimal therapeutic range.

CONFLICT OF INTERESTS

The authors declare that there are no conflict of interests.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.